PNC Financial Services Group
BIVV

PNC Financial Services Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

PNC Financial Services Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-137,103
Closed -$7.39M – 4378
2017
Q4 		$7.39M Buy
137,103
+115,310
+529% +$6.31M 0.01% 597
2017
Q3 		$1.24M Sell
21,793
-10,648
-33% -$624K ﹤0.01% 1201
2017
Q2 		$1.95M Sell
32,441
-11,143
-26% -$635K ﹤0.01% 1016
2017
Q1 		$2.37M Buy
+43,584
New +$2.15M ﹤0.01% 938

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

PNC Financial Services Group's BIVV Position: Q1 2018 in Review

PNC Financial Services Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 137,103 shares — an estimated $7.39M sold.

PNC Financial Services Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $7.39M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • PNC Financial Services Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • PNC Financial Services Group sold 137,103 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $7.39M.
  • PNC Financial Services Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • PNC Financial Services Group's Bioverativ Inc. Common Stock position peaked at $7.39M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on PNC Financial Services Group's 13F filing for Q1 2018, filed 11 May 2018.